ARTICLE | Clinical News
Velcade bortezomib regulatory update
February 16, 2015 8:00 AM UTC
Johnson & Johnson’s subsidiary Janssen-Cilag International N.V. said the European Commission approved an expanded label for Velcade bortezomib to include treatment of previously untreated mantle cell ...